Form 4 Filing for NEUROCRINE BIOSCIENCES INC

This filing details a Form 4 filed by Sharp Shalini, a director at NEUROCRINE BIOSCIENCES INC (NBIX), on May 27, 2026. The transaction involved the acquisition of 2,567 Restricted Stock Units (RSUs) with a transaction value of $0.00. These RSUs represent the right to receive one share of the Issuer's common stock upon vesting. The RSUs will vest in full on May 27, 2027. Following the transaction, the reporting owner holds 2,567 shares of common stock indirectly. The filing was signed on May 29, 2026, by Darin Lippoldt, Attorney-in-Fact.